Efficacy and safety of the SQ house dust mite (HDM) sublingual immunotherapy-tablet in Japanese children with perennial allergic rhinitis: A randomised, double-blind, placebo-controlled phase 3 trial

被引：0
|
作者：
Okubo, K. [1 ]
Nolte, H. [2 ]
Okamoto, Y. [3 ]
Azuma, R. [4 ]
Natsui, K. [4 ]
Masuyama, K. [5 ]
机构：
[1] Nippon Med Sch, Tokyo, Japan
[2] ALK, Bedminster, NJ USA
[3] Chiba Univ, Chiba, Japan
[4] Torii Pharmaceut, Tokyo, Japan
[5] Yamanashi Univ, Kofu, Yamanashi, Japan
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0603
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [21] House dust mite immunotherapy in asthmatic patients: a randomised, double-blind, placebo-controlled trial
    Rodriguez Santos, O.
    Celio Murillo, R.
    Laurrabaquio Miranda, A.
    Cruz Suarez, M.
    Cuevas Castillejos, H.
    Khair, Abou F.
    Tinoco Moran, I
    ALLERGY, 2012, 67 : 410 - 410
  • [22] The efficacy and safety of house dust mite sublingual tablet to pediatric patients with perennial allergic rhinitis
    Okamoto, Y.
    Fujieda, S.
    Okano, M.
    Kakudo, S.
    Hida, H.
    Tsuji, T.
    Masuyama, K.
    ALLERGY, 2018, 73 : 325 - 325
  • [23] Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Langer, Sarah Sella
    Cardili, Renata Nahas
    Lima Melo, Janaina Michelle
    Leme Ferriani, Mariana Paes
    Moreno, Adriana Santos
    Dias, Marina Mendonca
    Bueno-Filho, Roberto
    Candido Pocente, Renata Helena
    Roxo-Junior, Persio
    Silva, Jorgete
    Pereira Valera, Fabiana Cardoso
    Coelho, Eduardo Barbosa
    Santos Galvao, Clovis Eduardo
    Carmona, Fabio
    Aragon, Davi Casale
    Arruda, Luisa Karla
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 539 - +
  • [24] Double-blind placebo-controlled sublingual-oral immunotherapy (SLIT) in house dust mite (HDM) asthma.
    Bousquet, J
    Andre, C
    Scheinman, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 711 - 711
  • [25] Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (Dpt) in children
    Hirsch, T
    Sahn, M
    Leupold, W
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 1997, 8 (01) : 21 - 27
  • [26] Consistent Efficacy and Safety Among Children, Adolescents, and Adults with Allergic Rhinitis/ Rhinoconjunctivitis Receiving 12 SQ-HDM House Dust Mite Sublingual Immunotherapy Tablet
    Nolte, Hendrik
    Bernstein, David
    Foss-Skiftesvik, Majken Hougaard
    Gagnon, Remi
    Matsuoka, Tomokazu
    Azuma, Ryuji
    Pfaar, Oliver
    Schuster, Antje
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02)
  • [27] Fast Onset of Action of Sublingual Immunotherapy in House Dust Mite-Induced Allergic Rhinitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Wang, De-Hui
    Chen, Lei
    Cheng, Lei
    Li, Ke-Nan
    Yuan, Hu
    Lu, Ji-Hong
    LARYNGOSCOPE, 2013, 123 (06): : 1334 - 1340
  • [28] Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial
    Demoly, Pascal
    Emminger, Waltraud
    Rehm, Dorte
    Backer, Vibeke
    Tommerup, Lene
    Kleine-Tebbe, Joerg
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : 444 - +
  • [29] SAFETY OF THE HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IN A PEDIATRIC ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS TRIAL
    Caimmi, D.
    Nolte, H.
    Pfaar, O.
    Foss-Skiftesvik, M.
    Osterdal, A.
    Schuster, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S18 - S18
  • [30] House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study
    Mortemousque, B
    Bertel, F
    De Casamayor, J
    Verin, P
    Colin, J
    CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (04): : 464 - 469
12345